Vitarani Dwi Ananda Ningrum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Vitarani Dwi Ananda Ningrum has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Zullies Ikawati
Affiliation Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Daerah Istimewa Yogyakarta, Indonesia
6 shared publications- Ari Wibowo
Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Islam Indonesia, Indonesia
5 shared publications Ahmad Hamim Sadewa
Affiliation Faculty of Medicine, Universitas Gadjah Mada, Sleman, Daerah Istimewa Yogyakarta, Indonesia
4 shared publicationsRahma Yuantari
4 shared publicationsAhmad H. Sadewa
Department of Biochemistry, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
3 shared publicationsIrwan Nuryana Kurniawan
Department of Psychology, Universitas Islam Indonesia, Kaliurang St. Km 14.5, Yogyakarta, Indonesia, 55584
3 shared publications
Latest Publications
- Open Access
- 23 January 2026
- Published by Belitung Raya Foundation in Belitung Nursing Journal
- Vol. 12 (1) , 58-67
Home medication review and drug-related problems in patients with chronic diseases at primary health centers in Yogyakarta, Indonesia: A cross-sectional multicenter study
Background: The high incidence of Drug-Related Problems (DRPs), including medication adherence among patients with chronic diseases, especially during no direct monitoring by health workers, becomes a challenge to therapy success. Home Medication Review (HMR) is an alternative solution in primary healthcare services to avoid further complications. Objective: This study aimed to analyze DRPs, their affecting factors, and DRP interventions for patients with chronic diseases in primary health centers (Puskesmas) through HMR. Methods: A quantitative, cross-sectional observational study using purposive sampling was conducted in several Puskesmas in Yogyakarta from February to May 2023. The collaborative HMR involved healthcare providers at each Puskesmas. DRPs were assessed based on observations and semi-structured interviews. The DRP classification followed PCNE V9.1, and medication adherence was measured using both pill counts and self-report via the MARS-10 questionnaire. Data were analyzed using SPSS 25.0 to perform logistic regression with a 95% confidence level. Results: A total of 544 patients, comprising 269 adults and 275 older patients, were involved. Older patients experienced more DRPs than the adults (94.2% vs 84.8%). The most DRP experienced by both age groups was ineffective therapies, with the two most frequent causes being related to patient factors. Among the adults, hypertension comorbidity, number of medications, and BMI factors were associated with DRPs (p < 0.05). In contrast, no factors correlated with DRPs in the older patients. There was fair agreement between pill count and MARS-10 regarding medication adherence for both adults and older patients (kappa coefficients of 0.298 and 0.355, respectively). Conclusion: Patients in primary health facilities with hypertension and using at least three medications have over a three-fold increased risk of experiencing DRPs. Healthcare providers, including pharmacists, nurses, and physicians, should collaborate to identify medication-related issues and provide personalized advice and management plans to enhance medication adherence. This study highlights the need for a standardized, structured HMR program, not merely as a patient home visit but also to better control chronic diseases.
- 23 January 2026
- Published by Belitung Raya Foundation in Belitung Nursing Journal
- Vol. 12 (1) , 58-67
Open AccessHome medication review and drug-related problems in patients with chronic diseases at primary health centers in Yogyakarta, Indonesia: A cross-sectional multicenter study
Background: The high incidence of Drug-Related Problems (DRPs), including medication adherence among patients with chronic diseases, especially during no direct monitoring by health workers, becomes a challenge to therapy success. Home Medication Review (HMR) is an alternative solution in primary healthcare services to avoid further complications. Objective: This study aimed to analyze DRPs, their affecting factors, and DRP interventions for patients with chronic diseases in primary health centers (Puskesmas) through HMR. Methods: A quantitative, cross-sectional observational study using purposive sampling was conducted in several Puskesmas in Yogyakarta from February to May 2023. The collaborative HMR involved healthcare providers at each Puskesmas. DRPs were assessed based on observations and semi-structured interviews. The DRP classification followed PCNE V9.1, and medication adherence was measured using both pill counts and self-report via the MARS-10 questionnaire. Data were analyzed using SPSS 25.0 to perform logistic regression with a 95% confidence level. Results: A total of 544 patients, comprising 269 adults and 275 older patients, were involved. Older patients experienced more DRPs than the adults (94.2% vs 84.8%). The most DRP experienced by both age groups was ineffective therapies, with the two most frequent causes being related to patient factors. Among the adults, hypertension comorbidity, number of medications, and BMI factors were associated with DRPs (p < 0.05). In contrast, no factors correlated with DRPs in the older patients. There was fair agreement between pill count and MARS-10 regarding medication adherence for both adults and older patients (kappa coefficients of 0.298 and 0.355, respectively). Conclusion: Patients in primary health facilities with hypertension and using at least three medications have over a three-fold increased risk of experiencing DRPs. Healthcare providers, including pharmacists, nurses, and physicians, should collaborate to identify medication-related issues and provide personalized advice and management plans to enhance medication adherence. This study highlights the need for a standardized, structured HMR program, not merely as a patient home visit but also to better control chronic diseases.
- Open Access
- 31 July 2025
- Published by MIDWINERSLION : Jurnal Kesehatan STIKes Buleleng in PROSIDING SIMPOSIUM KESEHATAN NASIONAL
- Vol. 4 (1)
ANALISIS PENGGUNAAN NITRAT, β-BLOCKER DAN ANTIPLATELET PADA PASIEN UNSTABLE ANGINA PECTORIS DI RUMAH SAKIT UMUM DAERAH KABUPATEN BULELENG: SEBUAH STUDI DESKRIPTIF
Unstable angina pectoris (UAP) merupakan bagian dari sindrom koroner akut yang memerlukan terapi farmakologis tepat. Penelitian retrospektif ini menganalisis penggunaan nitrat, β-blocker, dan antiplatelet pada 115 pasien UAP rawat inap di RSUD Buleleng (Januari–Desember 2024). Hasil menunjukkan mayoritas pasien menerima antiplatelet (aspirin 81,7%, clopidogrel 89,6%), sedangkan penggunaan nitrat (70,4%) dan β-blocker (73,0%) juga tinggi dengan variasi dosis. Mayoritas pasien berusia 45–59 tahun dengan proporsi gender seimbang. Studi lanjut diperlukan terkait efektivitas dan efek samping obat untuk strategi pengobatan optimal. Kata kunci : UAP, Antiplatelet, Nitrat, β -Blocker
- 31 July 2025
- Published by MIDWINERSLION : Jurnal Kesehatan STIKes Buleleng in PROSIDING SIMPOSIUM KESEHATAN NASIONAL
- Vol. 4 (1)
Open AccessANALISIS PENGGUNAAN NITRAT, β-BLOCKER DAN ANTIPLATELET PADA PASIEN UNSTABLE ANGINA PECTORIS DI RUMAH SAKIT UMUM DAERAH KABUPATEN BULELENG: SEBUAH STUDI DESKRIPTIF
Unstable angina pectoris (UAP) merupakan bagian dari sindrom koroner akut yang memerlukan terapi farmakologis tepat. Penelitian retrospektif ini menganalisis penggunaan nitrat, β-blocker, dan antiplatelet pada 115 pasien UAP rawat inap di RSUD Buleleng (Januari–Desember 2024). Hasil menunjukkan mayoritas pasien menerima antiplatelet (aspirin 81,7%, clopidogrel 89,6%), sedangkan penggunaan nitrat (70,4%) dan β-blocker (73,0%) juga tinggi dengan variasi dosis. Mayoritas pasien berusia 45–59 tahun dengan proporsi gender seimbang. Studi lanjut diperlukan terkait efektivitas dan efek samping obat untuk strategi pengobatan optimal. Kata kunci : UAP, Antiplatelet, Nitrat, β -Blocker
- Open Access
- 31 July 2025
- Published by Sekolah Tinggi Ilmu Kesehatan Buleleng in JURNAL FARMASI KRYONAUT
- Vol. 4 (2) , 90-100
EVALUASI TERAPI OBAT PADA SINDROM KORONER AKUT : SCOPING REVIEW
Latar Belakang: Sindrom Koroner Akut (SKA) merupakan penyebab utama kematian global, dengan terapi farmakologis sebagai bagian penting dalam manajemen klinis. Namun, efektivitas terapi obat, interaksi obat, dan parameter hematologi esensial yang relevan masih perlu dievaluasi secara sistematis. Tujuan: Scoping review ini bertujuan untuk mengkaji efektivitas terapi obat pada pengelolaan SKA, termasuk parameter hematologi pasien untuk keberlangsungan terapi yang akan diberikan. Metode: Scoping review dilakukan dengan pencarian literatur dari PubMed, Science Direct, dan Google Scholar menggunakan kata kunci terkait terapi obat dan parameter hematologi pada SKA. Artikel yang dipilih memenuhi kriteria inklusi dengan terapi farmakologis beserta hasil outcome klinis yaitu parameter hematologi pada penyakit Sindrom Koroner Akut yang mencakup STEMI, N-STEMI dan Agina Pektoris Tidak Stabil, artikel teks lengkap, rentang waktu 2020–2024, artikel review dan studi kasus dikecualikan. Hasil: Dari 3.697 artikel yang ditemukan, terdapat 10 artikel yang relevan sesuai dengan kriteria inklusi Hasil menunjukkan bahwa terapi obat pada Sindrom Koroner Akut yang mencakup APTS, NSTEMI dan STEMI ditemukan pada golongan antiplatelet, antikoagulan, β1-blockers, dan kombinasi risiko beserta parameter hematologi yang meliputi troponin, NLR, MLR, kadar hs-cTnI, leukosit, neutrofil, eosinofil, rasio leukosif dan PRA Kesimpulan: Evaluasi terapi farmakologis yang menyeluruh pada pasien dengan Sindrom Koroner Akut (SKA), terutama dalam hal interaksi obat dan pemilihan kombinasi terapi yang optimal dapat memberikan manfaat klinis yang lebih baik, sementara pemantauan biomarker hematologis seperti troponin, NLR, MLR, hs-cTnI , leukosit, neutrofil, eosinofil, rasio leukosif dan PRA menjadi alat prognostik penting untuk stratifikasi risiko. Kata Kunci: sindrome koroner akut, terapi obat, parameter hematologis
- 31 July 2025
- Published by Sekolah Tinggi Ilmu Kesehatan Buleleng in JURNAL FARMASI KRYONAUT
- Vol. 4 (2) , 90-100
Open AccessEVALUASI TERAPI OBAT PADA SINDROM KORONER AKUT : SCOPING REVIEW
Latar Belakang: Sindrom Koroner Akut (SKA) merupakan penyebab utama kematian global, dengan terapi farmakologis sebagai bagian penting dalam manajemen klinis. Namun, efektivitas terapi obat, interaksi obat, dan parameter hematologi esensial yang relevan masih perlu dievaluasi secara sistematis. Tujuan: Scoping review ini bertujuan untuk mengkaji efektivitas terapi obat pada pengelolaan SKA, termasuk parameter hematologi pasien untuk keberlangsungan terapi yang akan diberikan. Metode: Scoping review dilakukan dengan pencarian literatur dari PubMed, Science Direct, dan Google Scholar menggunakan kata kunci terkait terapi obat dan parameter hematologi pada SKA. Artikel yang dipilih memenuhi kriteria inklusi dengan terapi farmakologis beserta hasil outcome klinis yaitu parameter hematologi pada penyakit Sindrom Koroner Akut yang mencakup STEMI, N-STEMI dan Agina Pektoris Tidak Stabil, artikel teks lengkap, rentang waktu 2020–2024, artikel review dan studi kasus dikecualikan. Hasil: Dari 3.697 artikel yang ditemukan, terdapat 10 artikel yang relevan sesuai dengan kriteria inklusi Hasil menunjukkan bahwa terapi obat pada Sindrom Koroner Akut yang mencakup APTS, NSTEMI dan STEMI ditemukan pada golongan antiplatelet, antikoagulan, β1-blockers, dan kombinasi risiko beserta parameter hematologi yang meliputi troponin, NLR, MLR, kadar hs-cTnI, leukosit, neutrofil, eosinofil, rasio leukosif dan PRA Kesimpulan: Evaluasi terapi farmakologis yang menyeluruh pada pasien dengan Sindrom Koroner Akut (SKA), terutama dalam hal interaksi obat dan pemilihan kombinasi terapi yang optimal dapat memberikan manfaat klinis yang lebih baik, sementara pemantauan biomarker hematologis seperti troponin, NLR, MLR, hs-cTnI , leukosit, neutrofil, eosinofil, rasio leukosif dan PRA menjadi alat prognostik penting untuk stratifikasi risiko. Kata Kunci: sindrome koroner akut, terapi obat, parameter hematologis
- Open Access
- 31 March 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (1) , 739-748
Effectiveness and Adverse Drug Reaction Mechanisms Associated with Valproic Acid Use: A Cross-Sectional Prospective Study in Indonesia
Valproic acid (VPA) is a broad-spectrum antiepileptic drug that can also be used to treat bipolar and other neurological disorders. Meanwhile, interindividual variability is known to significantly affect the clinical response to VPA use. This study aims to analyze the factors that affect the clinical response to VPA and prevalence of VPA adverse drug reactions (ADRs). An observational study with a prospective cross-sectional design was conducted by involving 87 outpatients from two private hospitals known for their excellence in neurology. The data on patients’ demographic characteristics, the treatment received, clinical response to VPA, and adverse drug reactions (ADRs) were obtained from the medical records and patient interview. The clinical response to VPA was also confirmed by the patients’ attending doctor, while the ADRs referred to the laboratory data on liver function and data from the medical records. A total of 84 patients (96.6%) receiving VPA showed the expected clinical response. There were no factors correlating with the effectiveness of VPA use (p>0.05). However, more than half of the patients experienced ADRs due to VPA use, including weight gain, hair loss, and hepatotoxicity. Although most of the patients have had their disorders controlled by VPA, an individualized approach is required to avoid the prevalence of ADRs, especially for patients with high-risk factors.
- 31 March 2025
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (1) , 739-748
Open AccessEffectiveness and Adverse Drug Reaction Mechanisms Associated with Valproic Acid Use: A Cross-Sectional Prospective Study in Indonesia
Valproic acid (VPA) is a broad-spectrum antiepileptic drug that can also be used to treat bipolar and other neurological disorders. Meanwhile, interindividual variability is known to significantly affect the clinical response to VPA use. This study aims to analyze the factors that affect the clinical response to VPA and prevalence of VPA adverse drug reactions (ADRs). An observational study with a prospective cross-sectional design was conducted by involving 87 outpatients from two private hospitals known for their excellence in neurology. The data on patients’ demographic characteristics, the treatment received, clinical response to VPA, and adverse drug reactions (ADRs) were obtained from the medical records and patient interview. The clinical response to VPA was also confirmed by the patients’ attending doctor, while the ADRs referred to the laboratory data on liver function and data from the medical records. A total of 84 patients (96.6%) receiving VPA showed the expected clinical response. There were no factors correlating with the effectiveness of VPA use (p>0.05). However, more than half of the patients experienced ADRs due to VPA use, including weight gain, hair loss, and hepatotoxicity. Although most of the patients have had their disorders controlled by VPA, an individualized approach is required to avoid the prevalence of ADRs, especially for patients with high-risk factors.
- Open Access
- 1 January 2025
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 52 (62)
Short-term treatment of multidrug-resistant tuberculosis: a multicenter study of therapeutic effectiveness and adverse drug reactions in Yogyakarta, Indonesia
This study analyzed the therapeutic effectiveness, ADRs, and their influencing factors in multidrug-resistant tuberculosis (MDR-TB) patients. We conducted a cross-sectional study involving patients in
- 1 January 2025
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 52 (62)
Open AccessShort-term treatment of multidrug-resistant tuberculosis: a multicenter study of therapeutic effectiveness and adverse drug reactions in Yogyakarta, Indonesia
This study analyzed the therapeutic effectiveness, ADRs, and their influencing factors in multidrug-resistant tuberculosis (MDR-TB) patients. We conducted a cross-sectional study involving patients in
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 322-328
Formulae for estimation of kidney function as an approach to calculating drug doses: A scoping review
Background: The kidneys are the main organ for drug excretion, and it is critical to assess kidney function when designing dosage regimens for drugs that undergo renal elimination. Various formulae have been used to estimate kidney function and safely adjust doses. Objective: This research reviewed studies that assessed patients' kidney function with various approaches to provide appropriate choices of kidney function estimation formulas based on patients' age and clinical conditions. Method: The search involved browsing scientific articles in PubMed and ScienceDirect with the keywords (("assessment") AND ("GFR") AND ("formula")) OR ("renal function") AND ("human")) AND (“Creatinine”). The articles included were those available in full text and English. Thirty articles addressing the formulae for kidney function assessment were reviewed. Result: The Schwartz formula is more appropriate for pediatric and adult patients, whereas the creatinine-based chronic kidney disease epidemiology (CKD-EPI) formula can be used in geriatrics, obese patients, and patients already known to have decreased kidney function. The cystatin C-based CKD-EPI formula is for patients with HIV and post-transplant patients. Conclusion: This study identified that physiological conditions, especially patients’ age and pathology, should be considered in devising formulae to estimate kidney function to accurately calculate safe drug doses.
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 322-328
Formulae for estimation of kidney function as an approach to calculating drug doses: A scoping review
Background: The kidneys are the main organ for drug excretion, and it is critical to assess kidney function when designing dosage regimens for drugs that undergo renal elimination. Various formulae have been used to estimate kidney function and safely adjust doses. Objective: This research reviewed studies that assessed patients' kidney function with various approaches to provide appropriate choices of kidney function estimation formulas based on patients' age and clinical conditions. Method: The search involved browsing scientific articles in PubMed and ScienceDirect with the keywords (("assessment") AND ("GFR") AND ("formula")) OR ("renal function") AND ("human")) AND (“Creatinine”). The articles included were those available in full text and English. Thirty articles addressing the formulae for kidney function assessment were reviewed. Result: The Schwartz formula is more appropriate for pediatric and adult patients, whereas the creatinine-based chronic kidney disease epidemiology (CKD-EPI) formula can be used in geriatrics, obese patients, and patients already known to have decreased kidney function. The cystatin C-based CKD-EPI formula is for patients with HIV and post-transplant patients. Conclusion: This study identified that physiological conditions, especially patients’ age and pathology, should be considered in devising formulae to estimate kidney function to accurately calculate safe drug doses.
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 286-291
Use of anticoagulant drugs for hospitalised patients: A multicentre study
Background: Anticoagulants are indicated for several types of diseases with progression related to coagulation. Patients administered this drug need to be evaluated by the pharmacist regarding its effectiveness and possible side effects. Objective: This research aimed to analyse the profile use of anticoagulants among patients at Yogyakarta Hospital. Method: This research was a multicentre study conducted retrospectively using the medical records of inpatients who received anticoagulants. Result: Among a total of 486 respondents, the majority were male (63.58%), and the adult age category (18-59 years) was 55.76%. Most anticoagulants were used in cases of cardiovascular disease, diagnosed with NSTEMI as much as 20.21%. The most used anticoagulant drug was heparin (48.9%), followed by fondaparinux (34.3%) and enoxaparin (16.8%). The most duration of anticoagulant use was one to four days (73.02%) with the dose range being 200-1000 units/day. Conclusion: Heparin was the anticoagulant widely used in patients with NSTEMI. Although the elderly were the group most at risk of ADR due to anticoagulants, most of these drugs were precisely taken by adults, who also required serious attention. Further research is needed to provide a more comprehensive approach to anticoagulant therapy.
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 286-291
Use of anticoagulant drugs for hospitalised patients: A multicentre study
Background: Anticoagulants are indicated for several types of diseases with progression related to coagulation. Patients administered this drug need to be evaluated by the pharmacist regarding its effectiveness and possible side effects. Objective: This research aimed to analyse the profile use of anticoagulants among patients at Yogyakarta Hospital. Method: This research was a multicentre study conducted retrospectively using the medical records of inpatients who received anticoagulants. Result: Among a total of 486 respondents, the majority were male (63.58%), and the adult age category (18-59 years) was 55.76%. Most anticoagulants were used in cases of cardiovascular disease, diagnosed with NSTEMI as much as 20.21%. The most used anticoagulant drug was heparin (48.9%), followed by fondaparinux (34.3%) and enoxaparin (16.8%). The most duration of anticoagulant use was one to four days (73.02%) with the dose range being 200-1000 units/day. Conclusion: Heparin was the anticoagulant widely used in patients with NSTEMI. Although the elderly were the group most at risk of ADR due to anticoagulants, most of these drugs were precisely taken by adults, who also required serious attention. Further research is needed to provide a more comprehensive approach to anticoagulant therapy.
- Open Access
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 197-203
Vancomycin bioanalysis for TDM services by using immunoassay and HPLC: A scoping review
Background: Administration of vancomycin in treating infections caused by Methicillin-resistant Staphylococcus aureus (MRSA) requires therapeutic drug monitoring (TDM). The immunoassay method and high-performance liquid chromatography (HPLC) are the two methods of choice for examining vancomycin levels, with their respective advantages. Objective: This study aims to review the validity of immunoassay and HPLC methods, as well as consider which method is appropriate, effective, and efficient for TDM in the clinical setting. Method: Related articles were searched for using the keywords "immunoassay", "vancomycin", "HPLC", "bioanalysis", and "human" in the PubMed, Google Scholar, and Science Direct databases. Result: A total of 20 publications examined immunoassays, whereas 23 articles covered HPLC. Both the immunoassay and HPLC methods provided acceptable bioanalytical validation values. Conclusion: The immunoassay method is an option for routine sample analysis that requires fast results, but this method is not recommended for patients with high immunoglobulin levels. The HPLC method is a choice because it offers better selectivity and sensitivity.
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 197-203
Open AccessVancomycin bioanalysis for TDM services by using immunoassay and HPLC: A scoping review
Background: Administration of vancomycin in treating infections caused by Methicillin-resistant Staphylococcus aureus (MRSA) requires therapeutic drug monitoring (TDM). The immunoassay method and high-performance liquid chromatography (HPLC) are the two methods of choice for examining vancomycin levels, with their respective advantages. Objective: This study aims to review the validity of immunoassay and HPLC methods, as well as consider which method is appropriate, effective, and efficient for TDM in the clinical setting. Method: Related articles were searched for using the keywords "immunoassay", "vancomycin", "HPLC", "bioanalysis", and "human" in the PubMed, Google Scholar, and Science Direct databases. Result: A total of 20 publications examined immunoassays, whereas 23 articles covered HPLC. Both the immunoassay and HPLC methods provided acceptable bioanalytical validation values. Conclusion: The immunoassay method is an option for routine sample analysis that requires fast results, but this method is not recommended for patients with high immunoglobulin levels. The HPLC method is a choice because it offers better selectivity and sensitivity.
- Open Access
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 222-227
Analysis of drug-related problems in the home medication review practice by the master of pharmacy students
Background: Master’s students are required to perform community service (CS), so a strategy is needed to merge CS into a course and make it a learning method that can be sustainably evaluated. Objective: This study aimed to analyse patients’ problems in using, storing, and disposing of drugs through home medication review (HMR) by master’s students of pharmacy. Subjective self-assessment assesses students’ performance in fulfilling the relevant competencies. Method: This cross-sectional study, conducted for four months, involved 225 patients living near the students’ residences. Semi-structured interviews collected data on subject characteristics and how the patients/family members managed drugs at home. Result: Nine master’s students practised HMR to achieve the learning outcomes of the pharmaceutical care course. The most commonly identified drug-related problems (DRPs) were inappropriate timing or dosing interval (41.2%) and medication nonadherence (25%). Some patients (31.6%) stored drugs without adherence to the provisions, and 70.2% disposed of drugs directly in the trash can. Meanwhile, 88.9% of students strongly agreed that HMR could improve their ability to gather patient data and information. Conclusion: HMR is an excellent patient-oriented practice for master’s students to strengthen and refine their awareness of community needs regarding drug use and management by patients at home.
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 222-227
Open AccessAnalysis of drug-related problems in the home medication review practice by the master of pharmacy students
Background: Master’s students are required to perform community service (CS), so a strategy is needed to merge CS into a course and make it a learning method that can be sustainably evaluated. Objective: This study aimed to analyse patients’ problems in using, storing, and disposing of drugs through home medication review (HMR) by master’s students of pharmacy. Subjective self-assessment assesses students’ performance in fulfilling the relevant competencies. Method: This cross-sectional study, conducted for four months, involved 225 patients living near the students’ residences. Semi-structured interviews collected data on subject characteristics and how the patients/family members managed drugs at home. Result: Nine master’s students practised HMR to achieve the learning outcomes of the pharmaceutical care course. The most commonly identified drug-related problems (DRPs) were inappropriate timing or dosing interval (41.2%) and medication nonadherence (25%). Some patients (31.6%) stored drugs without adherence to the provisions, and 70.2% disposed of drugs directly in the trash can. Meanwhile, 88.9% of students strongly agreed that HMR could improve their ability to gather patient data and information. Conclusion: HMR is an excellent patient-oriented practice for master’s students to strengthen and refine their awareness of community needs regarding drug use and management by patients at home.
- Open Access
- 31 March 2024
- Published by Baiman Bauntung Batuah Center in Tropical Health and Medical Research
- Vol. 6 (1) , 27-41
Validation of Questionnaires and the Effect of Educational Videos on the Knowledge of Hyperlipidemia Patients at Banjarbaru Utara Primary Health Care
Hyperlipidemia patients have a high risk of cardiovascular disease and stroke. Low patient knowledge causes therapy failure. Education can be provided to overcome this problem. No questionnaire instrument can measure the level of knowledge of hyperlipidemia patients. The level of knowledge of hyperlipidemia patients at Banjarbaru Utara Primary Health Care has never been studied. The research aimed to validate the questionnaire and determine the effect of educational videos on patient knowledge at the Banjarbaru Utara Primary Health Care, Banjarbaru City, South Kalimantan. The research method used to validate the questionnaire was cross-sectional, while to determine the effect of educational videos on the patient's level of knowledge using a quasi-experimental method using One Group Pre – Post Design. The research was conducted in January – March 2024 at Banjarbaru Utara Primary Health Care. The study involved eight experts, 40 patients in questionnaire validation, and 100 patients to determine the effect of educational videos. The results of questionnaire content validation show that the Content Validity Ratio (CVR) value is in the range of 0.750 – 1.000, while the Content Validity Index (CVI) value is in the range of 0.875 – 1.000. The validity test with Person Correlation shows that ten out of 20 statements on the questionnaire are considered valid (>0.312). The Cronbach's Alpha value is 0.655, indicating the questionnaire is reliable. The patient's knowledge before being given the educational video had a score of 5.96 (scale 1 – 10), while after it, it had a score of 8.73. There was an increase in the level of knowledge, reaching 46.47%. The conclusion is that the Hyperlipidemia Knowledge Questionnaire (HKQ), which consists of 10 statements, is declared valid and reliable. Educational videos significantly influence (p-value 0.000) in increasing knowledge of hyperlipidemia patients.
- 31 March 2024
- Published by Baiman Bauntung Batuah Center in Tropical Health and Medical Research
- Vol. 6 (1) , 27-41
Open AccessValidation of Questionnaires and the Effect of Educational Videos on the Knowledge of Hyperlipidemia Patients at Banjarbaru Utara Primary Health Care
Hyperlipidemia patients have a high risk of cardiovascular disease and stroke. Low patient knowledge causes therapy failure. Education can be provided to overcome this problem. No questionnaire instrument can measure the level of knowledge of hyperlipidemia patients. The level of knowledge of hyperlipidemia patients at Banjarbaru Utara Primary Health Care has never been studied. The research aimed to validate the questionnaire and determine the effect of educational videos on patient knowledge at the Banjarbaru Utara Primary Health Care, Banjarbaru City, South Kalimantan. The research method used to validate the questionnaire was cross-sectional, while to determine the effect of educational videos on the patient's level of knowledge using a quasi-experimental method using One Group Pre – Post Design. The research was conducted in January – March 2024 at Banjarbaru Utara Primary Health Care. The study involved eight experts, 40 patients in questionnaire validation, and 100 patients to determine the effect of educational videos. The results of questionnaire content validation show that the Content Validity Ratio (CVR) value is in the range of 0.750 – 1.000, while the Content Validity Index (CVI) value is in the range of 0.875 – 1.000. The validity test with Person Correlation shows that ten out of 20 statements on the questionnaire are considered valid (>0.312). The Cronbach's Alpha value is 0.655, indicating the questionnaire is reliable. The patient's knowledge before being given the educational video had a score of 5.96 (scale 1 – 10), while after it, it had a score of 8.73. There was an increase in the level of knowledge, reaching 46.47%. The conclusion is that the Hyperlipidemia Knowledge Questionnaire (HKQ), which consists of 10 statements, is declared valid and reliable. Educational videos significantly influence (p-value 0.000) in increasing knowledge of hyperlipidemia patients.